Impulse Control Disorders: Clinical Characteristics and Pharmacological Management

References

• American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed.Text Rev.Washington, DC: Author, 2000.
   Google Scholar
• Cunningham-Williams R, Cottler LB: The epidemiology of pathological gambling. Semin Clin Neuropsych. 2001; 6:155–166.
   Google Scholar
• Shaffer HJ, Hall MN, Vander Bilt J: Estimating the preva-lence of disordered gambling behavior in the United States and Canada: A research synthesis. Am J Public Health 1999; 89:1369–1376.
   PubMed Web of Science ®Google Scholar
• Goldman MJ: Kleptomania: Making sense of the nonsensical. Am J Psychiatry 1991; 148:986–996.
   PubMed Web of Science ®Google Scholar
• McElroy SL, Keck PE, Pope HG, Smith JMR, Strakowski SM: Compulsive buying: A report of 20 cases. J Clin Psychiatry 1994; 55:242–248.
   PubMed Web of Science ®Google Scholar
• Grant JE, Kim SW: Demographic and clinical features of 131 adult pathological gamblers. J Clin Psychiatry 2001; 62:957–962.
   PubMed Web of Science ®Google Scholar
• Ibanez A, Blanco C, Moreyra P. Saiz-Ruiz J: Gender dif-ferences in pathological gambling. J Clin Psychiatry 2003; 64:295–301.
   Google Scholar
• Ladd GT, Petry NM: Gender differences among pathological gamblers seeking treatment. Exp Clin Psychopharmacol 2002; 10:302–309.
   PubMed Web of Science ®Google Scholar
• Potenza MN, Steinberg MA, McLaughlin SD, Wu R, Rounsaville B, O'Malley SS: Gender-related differences in the characteristics of problem gamblers using a gambling helpline. Am J Psychiatry 2001; 158:1500–1505.
   PubMed Web of Science ®Google Scholar
• Volberg RA: The prevalence and demographics of pathological gamblers: implications for public health. Am J Pub Health 1994; 84:237–240.
   PubMed Web of Science ®Google Scholar
• McCormick RA, Russo AM, Ramirez LF, Taber JI: Affective disorders among pathological gamblers seeking treatment. Am J Psychiatry 1984; 141:215–218.
   PubMed Web of Science ®Google Scholar
• Black DW, Moyer T: Clinical features and psychiatric comorbidity of subjects with pathological gambling behavior. Psychiatr Serv 1998; 49:1434–1439.
   PubMed Web of Science ®Google Scholar
• Crockford DN, el-Guebaly N: Psychiatric comorbidity in pathological gambling: A critical review. Can J Psychiatry 1998; 43:43–50.
   PubMed Web of Science ®Google Scholar
• Cunningham-Williams RM, Collier LB, Compton WM 3rd, Spitznagel EL: Taking chances: Problem gamblers and mental health disorders-results from the St. Louis Epidemiologic Catchment Area Study. Am J Public Health 1998; 88:1093–1096.
   PubMed Web of Science ®Google Scholar
• Grant JE, Kim SW: Comorbidity of impulse control disorders among pathological gamblers. Acta Psychiatr Scand 2003; 108:203–207.
   PubMed Web of Science ®Google Scholar
• Specker SM, Carlson GA, Christenson GA, Marcotte M: Impulse control disorders and attention deficit dis-order in pathological gamblers. Ann Clin Psychiatry 1995; 7:175–179.
   PubMedGoogle Scholar
• Linden RD, Pope HG Jr, Jonas JM: Pathological gambling and major affective disorder: Preliminary fmdings. J Clin Psychiatry 1986; 47:201–203.
   PubMed Web of Science ®Google Scholar
• Ramirez LF, McCormack RA, Russo AM, Taber JI: Patterns of substance abuse in pathological gamblers undergoing treatment. Addict Behav. 1983; 8:425–428.
   PubMed Web of Science ®Google Scholar
• Roy A, Adinoff B, Roehrich L, Lamparski D, Custer R, Lorenz V. Barbaccia M, Guidotti A, Costa E, Linnoila M: Pathological gambling: A psychobiological study. Arch Gen Psychiatry 1988; 45:369–373.
   PubMed Web of Science ®Google Scholar
• Black DW, Moyer T, Schlosser S: Quality of life and family history in pathological gambling. J Nerv Ment Dis 2003; 191:124–126.
   PubMed Web of Science ®Google Scholar
• Slutske WS, Eisen S, True WR, Lyons MJ, Goldberg J, Tsuang M: Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch Gen Psychiatry 2000; 57:666–674.
   PubMed Web of Science ®Google Scholar
• Slutske WS, Eisen S, Xian H, True WR, Lyons MJ, Goldberg J, Tsuang M: A twin study of the association between pathological gambling and antisocial per-sonality disorder. J Abnorm Psychology 2001; 110: 297–308.
   PubMed Web of Science ®Google Scholar
• Hollander E, Frenkel M, DeCaria C, Trungold S, Stein DJ: Treatment of pathological gambling with clomipramine [letter]. Am J Psychiatry 1992; 149:710–711.
   PubMed Web of Science ®Google Scholar
• Zimmerman M, Breen R, Posternak MA: An open-label study of citalopram in the treatment of pathological gambling. J Clin Psychiatry 2002; 63:44–48.
   PubMed Web of Science ®Google Scholar
• De la Gandara JJ: Fluoxetine: Open-trial in pathological gambling. Presented at the 152 Annual Meeting of the American Psychiatric Association, May 16–21, Washington, DC, 1999 [Abstract] .
   Google Scholar
• Pallanti S, Baldini Rossi N, Sood E, Hollander E: Nefazodone treatment of pathological gambling: A pro-spective open-label controlled trial. J Clin Psychiatry 2002; 63:1034–1039.
   PubMed Web of Science ®Google Scholar
• Hollander E, DeCaria CM, Mari E, Wong CM, Mosovich S, Grossman R, Begaz T: Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry 1998; 155:1781–1783.
   PubMed Web of Science ®Google Scholar
• Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C: A randomized double-blind fluvox-amine/placebo crossover trial in pathological gambling. Biol Psychiatry 2000; 47:813–817.
   PubMed Web of Science ®Google Scholar
• Blanco C, Petkova E, Ibanez A, Saiz-Ruiz J: A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 2002; 14:9–15.
   PubMedGoogle Scholar
• Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli RM: A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 2002; 63:501–507.
   PubMed Web of Science ®Google Scholar
• Grant JE, Kim SW, Potenza MN, Blanco C, Ibanez A, Stevens LC, Zaninelli R: Paroxetine treatment of patho-logical gambling: A multi-center randomized controlled trial. Int Clin Psychopharmacol. 2003; 18:243–249.
   PubMed Web of Science ®Google Scholar
• Potenza MN: The neurobiology of pathological gam-bling. Semin Clin Neuropsychiatry 2001; 6:217–226.
   PubMedGoogle Scholar
• Crockford DN, el-Guebaly N: Naltrexone in the treatment of pathological gambling and alcohol dependence [letter]. Can J Psychiatry 1998; 43:86.
   PubMed Web of Science ®Google Scholar
• Kim SW, Grant JE: An open naltrexone treatment study of pathological gambling disorder. Int Clin Psychop-harmacol 2001; 16:285–289.
   PubMed Web of Science ®Google Scholar
• Kim SW, Grant JE, Adson DE, Shin YC: Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001; 49:914–921.
   PubMed Web of Science ®Google Scholar
• Kim SW, Grant JE, Adson DE, Remmel RP: A preliminary report on possible naltrexone and nonste-roidal analgesics interaction. J Clin Psychopharmacol. 2001; 21:632–634.
   PubMedGoogle Scholar
• Moskowitz JA: Lithium and lady luck: Use of lithium carbonate in compulsive gambling. NY State J Med 1980; 80:785–788.
   PubMedGoogle Scholar
• Haller R, Hinterhuber H: Treatment of pathological gambling with carbamazepine [letter]. Pharmacopsy-chiatry 1994; 27:129.
   PubMed Web of Science ®Google Scholar
• Pallanti S, Quercioli L, Sood E, Hollander E: Lithium and valproate treatment of pathological gambling: A randomized single-blind study. J Clin Psychiatry 2002; 63:559–564.
   PubMed Web of Science ®Google Scholar
• Hollander E, Pallanti S, Baldini-Rossi N: Sustained release lithium/placebo treatment response in bipolar spectrum pathological gamblers. Poster presented at the 42nd Annual New Clinical Drug Evaluation Unit Meeting, Boca Raton, FL, 2002.
   Google Scholar
• Potenza MN, Chambers RA: Schizophrenia and pathologi-cal gambling [letter]. Am J Psychiatry 2001; 158:497–498.
   Google Scholar
• Rugle L: The use of olanzapine in the treatment of video poker pathological gamblers. Presented at the conference entitled, "The Comorbidity of Pathological Gambling: A Current Research Synthesis", December 3–5, Las Vegas, NV, 2000 [Abstract].
   Google Scholar
• Grant JE, Kim SW: Clinical characteristics and associ-ated psychopathology of 22 patients with kleptomania. Compr Psychiatry 2002; 43:378–384.
   PubMed Web of Science ®Google Scholar
• McElroy SL, Pope HG, Hudson JI, Keck PE, White KL: Kleptomania: A report of 20 cases. Am J Psychiatry 1991; 148:652–657.
   PubMed Web of Science ®Google Scholar
• Presta S, Marazziti D, Dell'Osso L, Pfanner C, Pallanti S, Cassano GB: Kleptomania: Clinical features and comorbidity in an Italian sample. Compr Psychiatry 2002; 43:7–12.
   PubMed Web of Science ®Google Scholar
• Sarasalo E, Bergman B, Toth J: Personality traits and psychiatric and somatic morbidity among kleptomaniacs. Acta Psychiatr Scand 1996; 94:358–364.
   PubMed Web of Science ®Google Scholar
• Bayle FC, Caci H, Millet B, Richa S, Olie JP: Psycho-pathology and comorbidity of psychiatric disorders in patients with kleptomania. Am J Psychiatry 2003; 160: 1509–1513.
   PubMed Web of Science ®Google Scholar
• Grant JE: Family history and psychiatric comorbidity in persons with kleptomania. Compr Psychiatry 2003; 44: 437–441.
   PubMed Web of Science ®Google Scholar
• McElroy SL, Hudson JI, Pope HG, Keck PE, Aizley HG: The DSM-III-R impulse control disorders not elsewhere classified: Clinical characteristics and rela-tionship to other psychiatric disorders. Am J Psychiatry 1992; 149:318–327.
   PubMed Web of Science ®Google Scholar
• Chong SA, Low BL: Treatment of kleptomania with fluvoxamine. Acta Psychiatr Scand 1996; 93:314–315.
   Google Scholar
• Kraus JE: Treatment of kleptomania with paroxetine [letter]. J Clin Psychiatry 1999; 60:793.
   Google Scholar
• Dannon PN: Topiramate for the treatment of kleptomania: A case series and review of the literature. Clin Neurop-harmacol 2003; 26:1–4.
   PubMed Web of Science ®Google Scholar
• Dannon PN, Iancu I, Grunhaus L: Naltrexone treatment in kleptomanic patients. Human Psychopharmacol 1999; 14:583–585.
   Web of Science ®Google Scholar
• Burstein A: Fluoxetine-lithium treatment for kleptomania. J Clin Psychiatry 1992; 53:28–29.
   Google Scholar
• Durst R, Katz G, Knobler HY: Buspirone augmentation of fluvoxamine in the treatment of kleptomania. J Nerv MentDis 1997; 185:586–588
   Google Scholar
• Kmetz GF, McElroy SL, Collins DJ: Response of kleptomania and mixed mania to valproate. Am J Psychiatry 1997; 154:580–581.
   Google Scholar
• Grant JE, Kim SW: An open label study of naltrexone in the treatment of kleptomania. J Clin Psychiatry 2002; 63: 349–356.
   PubMed Web of Science ®Google Scholar
• Black DW: Compulsive buying: A review. J Clin Psychiatry 1996; 57[suppl 81:50–55.
   Google Scholar
• Christenson GA, Faber RJ, de Zwaan M, Raymond NC, Specker SM, Ekern MD, Mackenzie TB, Crosby RD, Crow SJ, Eckert ED, Mussel MP, Mitchell JE: Compul-sive buying: Descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry 1994; 55:5–11.
   PubMed Web of Science ®Google Scholar
• Schlosser S, Black DW, Repertinger S, Freet D: Compulsive buying: Demography, phenomenology, and comorbidity in 46 subjects. Gen Hosp Psychiatry 1994; 16:205–212.
   PubMed Web of Science ®Google Scholar
• Black DW, Repertinger S, Gaffney GR, Gabel J: Family history and psychiatric comorbidity in persons with compulsive buying: preliminary findings. Am J Psychiatry 1998; 155:960–963.
   PubMed Web of Science ®Google Scholar
• Lejoyeux M, Hourtane M, Ades J: Compulsive buying and antidepressants [letter]. J Clin Psychiatry 1995; 56:38.
   PubMed Web of Science ®Google Scholar
• Grant JE: Three cases of compulsive buying treated with naltrexone. Int J Psychiatry Clin Prac 2003; 7:223–225.
   Web of Science ®Google Scholar
• Black DW, Monahan P. Gabel J: Fluvoxamine in the treatment of compulsive buying. J Clin Psychiatry 1997; 58:159–163.
   PubMed Web of Science ®Google Scholar
• Koran LM, Bullock KD, Hartston HJ, Elliott MA, D'Andrea V: Citalopram treatment of compulsive shopping: An open-label study. J Clin Psychiatry 2002; 63:704–708.
   PubMed Web of Science ®Google Scholar
• Ninan PT, McElroy SL, Kane CP, Knight BT, Casuto LS, Rose SE, Marsteller FA, Nemeroff CB: Placebo-controlled study of fluvoxamine in the treatment of patients with compulsive buying. J Clin Psychopharmacol 2000; 20:362–366.
   PubMed Web of Science ®Google Scholar
• Black DW, Gabel J, Hansen J, Schlosser S: A double-blind comparison of fluvoxamine versus placebo in the treatment of compulsive buying disorder. Ann Clin Psychiatry 2000; 12:205–11.
   PubMedGoogle Scholar
• Koran LM, Chuong HW, Bullock KD, Smith SC: Citalo-pram for compulsive shopping disorder: An open-label study followed by double-blind discontinuation. J Clin Psychiatry 2003; 64:793–798.
   PubMed Web of Science ®Google Scholar